                         SEQUENCE LISTING

<110>  Antisense Therapeutics Ltd
 
<120>  Therapeutic uses and methods

<130>  530180PCT

<150>  AU 2019901540
<151>  2019-05-06

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  antisense oligonucleotide


<220>
<221>  methylcytosine
<222>  (1)..(1)

<220>
<221>  2'-O-(2-methoxyethyl) modified ribonucleosides
<222>  (1)..(3)

<220>
<221>  methyluracil
<222>  (2)..(2)

<220>
<221>  2'deoxyribonucleosides
<222>  (4)..(13)

<220>
<221>  methylcytosine
<222>  (7)..(7)

<220>
<221>  methyluracil
<222>  (13)..(13)

<220>
<221>  methylcytosine
<222>  (14)..(14)

<220>
<221>  2'-O-(2-methoxyethyl) modified ribonucleosides
<222>  (14)..(20)

<220>
<221>  methylcytosine
<222>  (15)..(15)

<220>
<221>  methyluracil
<222>  (17)..(17)

<220>
<221>  methyluracil
<222>  (18)..(18)

<220>
<221>  methylcytosine
<222>  (19)..(19)

<220>
<221>  methyluracil
<222>  (20)..(20)

<400>  1
cugagtctgt ttuccauucu                                                   20


<210>  2
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  antisense oligonucleotide


<220>
<221>  2'-O-(2-methoxyethyl) modified ribonucleosides
<222>  (1)..(5)

<220>
<221>  2'deoxyribonucleosides
<222>  (6)..(15)

<220>
<221>  methylcytosine
<222>  (9)..(9)

<220>
<221>  methylcytosine
<222>  (10)..(10)

<220>
<221>  methylcytosine
<222>  (12)..(12)

<220>
<221>  methylcytosine
<222>  (13)..(13)

<220>
<221>  2'-O-(2-methoxyethyl) modified ribonucleosides
<222>  (16)..(20)

<220>
<221>  methylcytosine
<222>  (18)..(18)

<220>
<221>  methylcytosine
<222>  (19)..(19)

<220>
<221>  methylcytosine
<222>  (20)..(20)

<400>  2
atatttttcc acctgtgccc                                                   20


<210>  3
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  antisense oligonucleotide

<400>  3
acagtgtacc tccttttctc                                                   20


